Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson’s Disease-Reference-Cited by-同舟云学术

Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson’s Disease

Published:2019-01-03 Issue:3 Volume:35 Page:699-710
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:Neurotox Res

Author:

Patricio Felipe,Parra Irving,Martínez Isabel,Pérez-Severiano Francisca,Montes Sergio,Aguilera José,Limón Ilhuicamina Daniel,Tizabi Yousef,Mendieta Liliana^ORCID

Funder

PRODEP-SEP

VIEP-BUAP

FELLOWSHIP CONACYT-MEXICO

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/s12640-018-9990-3.pdf

Reference79 articles.

1. Allbutt HN, Henderson JM (2007) Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson’s disease. J Neurosci Methods 159:195–202

2. Anderson DW, Neavin T, Smith JA, Schneider JS (2001) Neuroprotective effects of pramipexole in young and aged MPTP-treated mice. Brain Res 905:44–53

3. Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH (2009) A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease. Lancet Neurol 8:929–937

4. Benson MA, Fu Z, Kim JJ, Baldwin MR (2011) Unique ganglioside recognition strategies for clostridial neurotoxins. J Biol Chem 286:34015–34022

5. Blandini F, Armentero MT, Martignoni E (2008) The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 14(Suppl 2):S124–S129

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurotrophic fragments as therapeutic alternatives to ameliorate brain ageing;Neural Regeneration Research;2022

2. The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson’s disease;Neuroscience Research;2022-01

3. The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration;Neurotoxicity Research;2021-07-19

4. Synergistic antiallodynic and antihyperalgesic interaction between L-DOPA and celecoxib in parkinsonian rats is mediated by NO–cGMP–ATP-sensitive K+ channel;European Journal of Pharmacology;2020-12

5. An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease;Expert Opinion on Pharmacotherapy;2020-08-17